Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Sarcoma, Kaposi × Ritonavir × Clear all

Phase

Phase 2 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Acquired Immunodeficiency Syndrome 2 Sarcoma, Kaposi 1 Opportunistic Infections 1 Inflammation 1 HIV Infections 1 Epstein-Barr Virus Infections 1 Cytomegalovirus Infections 1 Coinfection 1

Interventions

Ritonavir 1 Nevirapine 1 Lopinavir 1 Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 Emtricitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00444379 2014-08-20

ARKS

University of California, San Francisco

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡